Alex Goldberg

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) and Gilead Sciences Inc. (NASDAQ:GILD) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/14/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) and Gilead Sciences Inc. (NASDAQ:GILD).

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a development stage company that engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States closed down in its previous session (-8.84%) on 7,883,774 shares traded. Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) is currently down (-22.96%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)

Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia closed down in its previous session (-2.31%) on 9,130,216 shares traded after Gilead Sciences announced the FDA has accepted for review the co's NDA for idelalisib, a targeted, oral inhibitor of PI3K delta, for the treatment of refractory indolent non-Hodgkin's lymphoma. Gilead Sciences Inc. (NASDAQ:GILD) is currently down (-4.61%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com